Posts

Showing posts from July, 2022

Global Rapid Diagnostic Tests Market is poised to see a decent growth of 4.5% from 2021 to 2026

Rapid diagnostic tests or RDTs are simple-to-use procedures that provide results in less than 20 minutes. Unlike most standard diagnostic tests, which are required to be sent to a lab for analysis, RDTs are done and results are provided at the point-of-care. Rapid tests are most frequently used to diagnose infectious diseases, such as flu, malaria, HIV, and COVID 19, among others. Impact of COVID-19 Pandemic on the Rapid Diagnostic Tests Market The global rapid diagnostic tests market has experienced a significant impact due to the COVID 19 pandemic. Although the demand for RDTs specifically for the detection of SARS-CoV-2 during 2020 and 2021 increased exponentially, the pandemic showed a negative impact on the sales of RDTs for cancer screening, blood glucose, cardiac markers, and other infectious diseases, among others. However, there has been a significant development in the rapid diagnostic tests market during the last two years; some of these are listed below: In October 2021

Global Cardiopulmonary Devices Market valued at $2.8 billion in 2021, is expected to witness a growth of 5% by 2026

Cardiopulmonary diseases include a range of medical conditions that affect the heart and lungs. Cardiopulmonary devices include heart-lung machines (HLM), percutaneous ventricular assist devices (PVAD), extracorporeal membrane oxygenation (ECMO) & Autotransfusion (ATS). These devices find usage in cardiac surgeries, pulmonary surgeries, congenital defects, cardiopulmonary bypass procedures, cardiogenic shock/respiratory failure, joint replacement surgeries, aneurysm surgeries, transplants, and other indications. Impact of Covid-19 Pandemic on the Cardiopulmonary Devices Market During 2020-2021, most of the patients infected with the Covid-19 virus showcased moderate symptoms and recovered quickly. However, some patients developed severe respiratory failure and required intensive care unit (ICU) admission and mechanical ventilation. To treat and save the lives of these severe Covid-19 patients, ECMO emerged as a promising treatment option. The ECMO machine supports both the he

Global Animal Health Market is expected to grow at a decent rate of 4% to reach $49 billion by 2026

Animal health is a medical disciple that emphasizes the prevention, detection, control, and therapeutics associated with veterinary diseases, disorders, and injuries. It covers a broad spectrum of animal species, including the domesticated and wild, with an extensive range of conditions that affect several species. It involves taking care of animals with the appropriate use of vaccines, anti-infective and anti-parasitic drugs, pharmaceutical specialty products, performance technologies, and value-added programs, such as livestock data management tools. Technological Innovations in Animal Health Market Scientific advancements, innovations, and emerging technologies from artificial intelligence to stem cell therapy and new generations of vaccines, have provided greater opportunities to predict, prevent, diagnose and treat animal illness more quickly, accurately, and safely. Veterinary researchers and developers continue to break new ground in reducing disease spread and its impact d

Global Cold Plasma Market is forecasted to witness a lucrative CAGR of 16% by 2026

Cold plasma, the fourth state of matter is a partially ionized gas comprising ions, electrons, ultraviolet photons, and reactive neutrals such as radicals, excited and ground-state molecules. Plasmas can also be artificially generated through gas dissociation by electricity, microwave radiation, or heat under ambient conditions. Due to the low heat capacity of cold plasma, it finds application in bioengineering, medicine, and therapeutics. Adoption of Cold Atmospheric Plasma (CAP) Therapy in Wound Healing Cold atmospheric plasma therapy is the latest approach in the field of plasma medicine. It consists of a mixture of reactive species that convey antimicrobial activity and affect human tissues. Owing to its environment-friendly and non-invasive nature, this technique has been admired and encouraged to use in different therapeutic regimes like wound healing, tissue regeneration, and skin infection management. Atmospheric pressure cold plasmas could affect different stages of wound

Global Gastrointestinal Endoscopic Devices Market is poised to witness a decent growth of 5% by 2026

Gastrointestinal (GI) diseases are disorders of the digestive system that involve a range of vital digestive organs such as mouth, esophagus, stomach, small and large bowels, rectum, anus, and GI connected organs (liver, gallbladder, and pancreas). Medical devices such as endoscopes, laparoscopes/surgical endoscopes, endotherapy devices, and laparoscopic devices play a vital role in the early & accurate diagnosis and treatment of potentially life-threatening GI diseases, which in turn opens up growth avenues for GI MedTech device manufacturers. Resurgence of Gastrointestinal Endoscopic Devices Market Post Covid-19 Pandemic Covid-19 has adversely impacted all the health services internationally and the GI MedTech industry was no different. Specialties such as gastroenterology were directly affected by Covid-19. The pandemic adversely impacted the workflow and safety of endoscopists, ancillary staff, and patients. Shortages of personal protective equipment (PPE), curtailed pa

Global Refurbished Medical Equipment Market is estimated to grow at a healthy rate of 12% to reach $18 billion by 2026

Refurbishment is defined as a systematic process that ensures the safety and effectiveness of the medical equipment without significantly changing the equipment’s or system’s performance, safety specifications, and/or changing intended use as in its original registration. Refurbishment of Medical Equipment Contributes to a Circular Economy Refurbished medical equipment serves the purpose of circular economy, by prolonging the life of the equipment, optimal use of resources, and reentering the business ecosystem. It also makes a positive contribution to the environment as it reduces waste generation and saves energy, resources, and raw materials. The DITTA estimates that around 30 MWh can be saved for each ton of refurbished medical imaging equipment. Cost Containment Strategies for Hospitals Drives the Refurbished Medical Equipment Market With the use of refurbished medical equipment's, the cost to hospitals can be reduced by 20-30 percent while continuing to guarantee safe

Global Renal Denervation Market valued at $140 Million in 2022, is growing at a lucrative growth rate of 40%

Resistant hypertension is a blood pressure that remains elevated above target levels despite use of anti-hypertensive medications. About 12-15% of the population treated for high blood pressure suffers from resistant hypertension. Renal denervation is a minimally invasive procedure used to treat resistant hypertension. As the geriatric population is rising, the number of people suffering from hypertension and the resistant hypertension is also growing which is driving the RDN market growth. Rising Prevalence of Hypertension is driving the Renal Denervation Market Growth According to WHO, currently more than one billion people across the world are suffering from hypertension which is expected to grow to 1.6 billion by 2025. WHO estimated that less than one in five people have their hypertension under control, either due to non-adherence or resistance to medication. This is leading to growing prevalence of hypertension/resistant hypertension, thereby driving the growth of the renal d

Global Clinical Trial Management System Market is poised to grow at a decent rate of 14% by 2026

A CTMS is a software system used to manage all the activities related to the setup, conduction, and closeout of clinical trials, including planning, preparation, tracking, monitoring, compliance, and reporting. The system aims to manage and maintain the tracking of patient data. A CTMS can be used for all four phases of a clinical trial. Adoption of CTMS among Researchers and Sponsors The implementation of a CTMS promises several advantages both for researchers and sponsors. Investigators and research coordinators spend less time manually entering data into many locations, which ultimately reduces errors made within a trial. CTMS also facilitates research reporting according to CDISC standards and proper budget calculations help conduct trials on time and keep the information up to date. Additionally, having a centralized location for all documents reduces the need for duplicate data entry and enables the research staff to easily identify any missing documents thus improving study

Global In-Vitro Fertilization Market valued at $1.25 billion in 2021, is expected to witness a decent growth of 8% by 2026

In-vitro fertilization (IVF) is a widely known type of assisted reproductive technology (ART) that involves complex series of procedures that are used to help with fertility or prevent genetic problems and assist with the conception of a child. Covid-19 Pandemic Impact on the Global In-Vitro Fertilization Market The news of the outbreak of the Covid-19 virus has severely impacted the in-vitro fertilization market in terms of the number of treatments and fertility services as IVF clinics had to shut down their businesses to reduce the spread of the virus. The virus also halted IVF tourism in several cost-effective destinations. However, the global IVF market is now in a recovery phase due to the efforts of IVF clinics to meet the pent-up need that was caused by the canceled treatments. The Covid-19 pandemic has paved the way for digital adoption in the IVF sector to gain operational efficiency and telehealth adoption to survive and thrive in unprecedented times. To overcome the ch

Global Sleep Apnea Devices Market valued at $5.5 billion in 2021, is set to witness a decent growth of 7% by 2026

Obstructive sleep apnea (OSA) is the most common form of sleep-disordered breathing (SDB). It is a partial or complete collapse of the upper airway caused by the relaxation of the muscles controlling the soft palate and tongue. The prevalence of OSA has been increasing steadily, and as per estimates, it affects ~3% to 20% of the general population. Technological Innovations is driving the Sleep Apnea Devices Market Growth The global sleep apnea devices market is a technology-driven market and is marked by constant product enhancements and market innovations. For instance, In October, 2021, AirAvant Medical introduced a new device called Bongo Rx for the treatment of obstructive sleep apnea (OSA). The device is touted as continuous positive airway pressure (CPAP) alternative and is clinically proven to treat mild to moderate OSA symptoms. In August 2021, Resmed , launched AirSense 11, the company’s next-generation PAP (positive airway pressure) device. AirSense 11 includes new feat

Global Precision Medicine Software Market is expected to witness a healthy CAGR of 10%

Precision medicine, sometimes known as "personalized medicine" is an innovative approach to tailoring disease prevention and treatment based on the individual’s unique characteristics and genetic make-up. Precision medicine software (platforms, data-sharing networks, clinical decision support software, AI-enabled, etc.) provides the healthcare/life sciences community with integrated data and data-driven insights to strengthen their precision medicine program. Shift from the Dominant One-Size-Fits-All Approach to Personalized Care Approach The precision medicine approach promises better clinical outcomes, safer medicines, and less wastage/cost savings. With the increasing demand to provide value to healthcare systems, drug developers have started to move away from the traditional one-size-fits-all approach to the personalized care approach. In 2020, the FDA approved 20 personalized drugs and biologics (39% of the new approvals). Precision medicines accounted for a quarte

Global Amniotic Products Market is projected to grow at a decent rate of 8% to reach $1 billion by 2026

Amniotic-derived products, including amniotic membrane and amniotic fluid products, are one subtype of orthobiologic that are considered a potential treatment option for augmentation of joint inflammation and healing. An amniotic membrane (AM) or amnion is a thin membrane forming a closed sac around the embryos or fetuses, and mammals and containing the amniotic  fluid. The most common types of amniotic membranes used are cryopreserved amniotic membranes and lyophilized amniotic membranes. Today, all amniotic, placental, and umbilical tissue-based products are classified by the FDA as human tissue without living cells. Growing Adoption of Amniotic Based Products in Wound Healing Amniotic membranes are made of structural collagen and extracellular matrix, regenerative, and biologically active cells, all of which interact with one another to regulate the healing processes. In the complex cascade of wound healing, a hallmark of a chronic non-healing wound is prolonged inflammation. T